Federal Register Notice: FDA has canceled the 7/17 meeting of the Anesthetic and Analgesic Drug Products Advisory Committee due to new information submitted to the application. The agency will continue to evaluate the application and, as needed, will announce future meeting dates in the Federal Register. To view this notice, click here.
